Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial
Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew recruitment sites and contacts were added, including Hospital Santa Izabel in Salvador, Brazil (Clarissa Mathias) and KLES Dr. Prabhakar Kore Hospital & Medical Research Centre (Rohan Bhise), along with associated investigators and phone numbers; older entries for these sites were removed or updated.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe site revision has been updated to v3.6.4, replacing v3.6.3, indicating a backend/UI update without changing the study details presented on the page.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded Fundacao Pio XII - Hospital de Barretos (Barretos, Brazil) with Josiane Mourao Dias at site 007-457 and phone +55 1733 216600; added Universitatsklinikum Augsburg with Bjorn Hackanson at site 007-2222 and phone +498214002729; added Local Institution 007-743-Ph3; updated Primary Completion date to 2028-10-31 and Study Completion date to 2029-10-31 with a Completed status. Removed prior site records and contacts for Xinjiang Medical University Cancer Hospital - Urumqi, Site 007-457, Site 007-2222, and associated not-yet-recruiting/contacts.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page's revision tag was bumped from v3.6.2 to v3.6.3, indicating a small update to the page's content or metadata.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page revision has been updated from v3.6.0 to v3.6.2, indicating a newer build of the page; this is an internal update with no explicit user-facing content changes.SummaryDifference0.0%

- Check67 days agoChange DetectedThe study record has been expanded with numerous new global locations and investigators, increasing the reach to 770 locations and updating site details and contacts. At the same time, several existing site entries and contacts were removed or changed, reflecting a cleanup or reorganization of local institutions.SummaryDifference0.3%

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.